Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Inglés
74
Historia
66
Estudio y enseñanza
64
Matemáticas
39
Procesamiento de datos
38
Administración
28
Psicología
28
Investigaciones
26
Desarrollo de programas para computadora
24
Diseño y construcción
24
Métodos estadísticos
24
Estadística
23
Metodología
23
Novela estadounidense
23
Modelos matemáticos
21
Estadística matemática
19
Estudiantes extranjeros
19
Java (Lenguaje de programación)
19
Probabilidades
19
Enfermedades
18
Filosofía
18
Historia y crítica
18
Lenguaje y lenguas
17
Física
16
Educación
15
Congresos
14
Manuales
14
Aspectos ambientales
13
Ingeniería de software
13
Psicopedagogía
13
-
6461por Gouripeddi, Ram, Groat, Danielle, Abdelrahman, Samir E., Cheatham, Tom, Cummins, Mollie, Eilbeck, Karen, LaSalle, Bernie, Sward, Katherine, Facelli, Julio C.“…Biomedical Informatics in Translational Research. 1 edition. Boston: Artech House; 2008. 264 p. 4. Payne PRO, Embi PJ, Niland J. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6462por Diamond, M P, Stewart, E A, Williams, A R W, Carr, B R, Myers, E R, Feldman, R A, Elger, W, Mattia-Goldberg, C, Schwefel, B M, Chwalisz, K“…Stewart participated as a site investigator in the phase 2 study of asoprisnil and served as a consultant to TAP Pharmaceuticals during the time of design and conduct of the studies while on the faculty of Harvard Medical School and Brigham and Women’s Hospital, Boston, MA. In the last 3 years, she has received support from National Institutes of Health grants HD063312, HS023418 and HD074711. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6463por Barnabas, Ruanne V., Brown, Elizabeth, Bershteyn, Anna, Miller, R. Scott, Wener, Mark, Celum, Connie, Wald, Anna, Chu, Helen, Wesche, David, Baeten, Jared M.“…This multisite trial will be conducted at seven sites in Seattle (UW), Los Angeles (UCLA), New Orleans (Tulane), Baltimore (UMB), New York City (NYU), Syracuse (SUNY-Upstate), and Boston (BMC). Inclusion criteria 1. Men or women 18 to 80 years of age inclusive, at the time of signing the informed consent. 2. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6464por Abdelaal, Mahmoud A.Z., Abdelrahman, Dyala, Cengiz, Mahir, Yavuzer, Hakan, Yavuzer, Serap, Bien, Ivy, Bhuva, Preeti, Pham, Jessica V, Siu, Royal, Tang, Mengdi, Ward, Ashley, Goodrow, Jason, Ludlum, Peter, Stark, Charles W., Perrine, Susan P.“…:Membership on an entity’s Board of Directors or advisory committees;Phoenicia Bioscience:Current Employment, Current equity holder in private company, Membership on an entity’s Board of Directors or advisory committees;Phoenicia Therapeutics:Membership on an entity’s Board of Directors or advisory committees, Patents & Royalties;Boston University School of Medicine:Current Employment, Patents & Royalties;Viracta Therapeutics:Patents & Royalties.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6465por Raman, Hari S., Flamand, Yael, Luskin, Marlise R., DeAngelo, Daniel J., Stone, Richard M., Garcia, Jacqueline S., Wadleigh, Martha, Charles, Anne, Copson, Kevin, Lindsley, R. Coleman, Vedula, Rahul S., Winer, Eric S.“…Stone: Bristol Meyers Squibb: Consultancy; Astellas: Membership on an entity's Board of Directors or advisory committees; BerGen Bio: Membership on an entity's Board of Directors or advisory committees; Boston Pharmaceuticals: Consultancy; Innate: Consultancy; Foghorn Therapeutics: Consultancy; Gemoab: Membership on an entity's Board of Directors or advisory committees; Glaxo Smith Kline: Consultancy; Celgene: Consultancy; Elevate Bio: Membership on an entity's Board of Directors or advisory committees; OncoNova: Consultancy; Syntrix/ACI: Membership on an entity's Board of Directors or advisory committees; Syndax: Membership on an entity's Board of Directors or advisory committees; Janssen: Consultancy; Agios: Consultancy, Research Funding; Amgen: Membership on an entity's Board of Directors or advisory committees; Aprea: Consultancy; Arog: Consultancy, Research Funding; Jazz: Consultancy; Macrogenics: Consultancy; Novartis: Consultancy, Research Funding; Actinium: Membership on an entity's Board of Directors or advisory committees; Abbvie: Consultancy; Syros: Membership on an entity's Board of Directors or advisory committees; Takeda: Consultancy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6466por Haiman, Christopher A, Hankinson, Susan E, Spiegelman, Donna, Colditz, Graham A, Willett, Walter C, Speizer, Frank E, Brown, Myles, Hunter, David J“…The protocol was approved by the Committee on Human Subjects, Brigham and Womens' Hospital, Boston, Massachusetts USA. Information regarding breast cancer risk factors was obtained from the 1976 baseline questionnaire, subsequent biennial questionnaires, and a questionnaire that was completed at the time of blood sampling. …”
Publicado 2000
Enlace del recurso
Enlace del recurso
Texto -
6467por Leiva, Orly, Campia, Umberto, Snyder, Julia, Barns, Briana, Rizzo, Samantha, Khairani, Candrika, Al-Samkari, Hanny, Karp Leaf, Rebecca, Rosovsky, Rachel P., Goodarzi, Katayoon, Fathi, Amir T., Goldhaber, Samuel Z., Piazza, Gregory, Hobbs, Gabriela“…Goldhaber: Bayer: Consultancy, Research Funding; Boehringer-Ingelheim: Consultancy, Research Funding; BMS: Research Funding; Boston Scientific BTG EKOS: Research Funding; Daiichi: Research Funding; Janssen: Research Funding; Pfizer: Consultancy, Research Funding; Agile: Consultancy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6468por CERN. Geneva“…In 1996 he left SBC and took a role with Fidelity Investments in Boston. Unable to stay away for long, he returned to SBC in 1997 while working for Perot Systems in Singapore. …”
Publicado 2007
Enlace del recurso
-
6469por Savona, Michael R., McCloskey, James K., Griffiths, Elizabeth A., Yee, Karen W.L., Al-Kali, Aref, Zeidan, Amer M., Deeg, H. Joachim, Patel, Prapti A., Sabloff, Mitchell, Keating, Mary-Margaret, Dao, Kim-Hien, Zhu, Nancy, Gabrail, Nashat, Fazal, Salman, Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop M., DeZern, Amy E., O'Connell, Casey L., Roboz, Gail J., Busque, Lambert, Wells, Richard A., Amin, Harshad, Randhawa, Jasleen K., Leber, Brian, Hao, Yong, Keer, Harold N., Azab, Mohammad, Garcia-Manero, Guillermo“…Griffiths:Celgene/BMS: Honoraria, Research Funding; Genentech Inc: Research Funding; Boston Biomedical: Honoraria; AbbVie Inc: Honoraria; Persimmune: Research Funding; Novartis: Honoraria, Research Funding; Alexion Pharmaceuticals: Honoraria, Research Funding; Astex Pharmceuticals: Research Funding. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6470por Savona, Michael R., McCloskey, James K, Griffiths, Elizabeth A., Yee, Karen, Zeidan, Amer M., Al-Kali, Aref, Deeg, H. Joachim, Patel, Prapti, Sabloff, Mitchell, Keating, Mary-Margaret, Dao, Kim-Hien, Zhu, Nancy, Gabrail, Nashat, Fazal, Salman, Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop, DeZern, Amy E., O'Connell, Casey L., Roboz, Gail J., Busque, Lambert, Wells, Richard A., Amin, Harshad, Randhawa, Jasleen K., Leber, Brian, Hao, Yong, Keer, Harold N., Azab, Mohammad, Garcia-Manero, Guillermo“…McCloskey: Pfizer: Consultancy; Takeda: Consultancy, Speakers Bureau; Incyte: Speakers Bureau; Novartis: Consultancy; COTA: Other: Equity Ownership; BMS: Honoraria, Speakers Bureau; Amgen: Speakers Bureau; Jazz: Consultancy, Speakers Bureau. Griffiths: Boston Biomedical: Consultancy; Celgene/Bristol-Myers Squibb: Consultancy, Honoraria, Research Funding; Abbvie: Consultancy, Honoraria; Taiho Oncology: Consultancy, Honoraria; Genentech: Research Funding; Astex Pharmaceuticals: Honoraria, Research Funding; Takeda Oncology: Consultancy, Honoraria; Novartis: Honoraria; Apellis Pharmaceuticals: Research Funding; Alexion Pharmaceuticals: Consultancy, Research Funding. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6471por Garcia-Manero, Guillermo, McCloskey, James K, Griffiths, Elizabeth A., Yee, Karen, Zeidan, Amer M., Al-Kali, Aref, Deeg, H. Joachim, Patel, Prapti, Sabloff, Mitchell, Keating, Mary-Margaret, Dao, Kim-Hien, Zhu, Nancy, Gabrail, Nashat Y., Fazal, Salman, Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop, DeZern, Amy E., O'Connell, Casey L., Roboz, Gail J., Busque, Lambert, Wells, Richard A., Amin, Harshad, Randhawa, Jasleen K., Leber, Brian, Hao, Yong, Keer, Harold N., Azab, Mohammad, Savona, Michael R.“…Griffiths: Alexion Pharmaceuticals: Consultancy, Research Funding; Abbvie: Consultancy, Honoraria; Taiho Oncology: Consultancy, Honoraria; Genentech: Research Funding; Novartis: Honoraria; Takeda Oncology: Consultancy, Honoraria; Astex Pharmaceuticals: Honoraria, Research Funding; Celgene/Bristol-Myers Squibb: Consultancy, Honoraria, Research Funding; Apellis Pharmaceuticals: Research Funding; Boston Biomedical: Consultancy. Yee: Paladin: Membership on an entity's Board of Directors or advisory committees; TaiHo: Membership on an entity's Board of Directors or advisory committees; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Genentech: Research Funding; Geron: Research Funding; Janssen: Research Funding; Jazz: Research Funding; MedImmune: Research Funding; Onconova: Research Funding; Tolero: Research Funding; AbbVie: Honoraria; Bristol-Myers Squibb/Celgene: Membership on an entity's Board of Directors or advisory committees; Otsuka: Membership on an entity's Board of Directors or advisory committees; Shattuck Labs: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees; F. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6472“…Variables such as pain (based on Visual Analogue Scale), symptom severity and functional status (based on Bostone/Levine symptom severity and functional status scale) and nerve conduction study were evaluated before and 10 weeks after the treatments. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6473por Shedleur-Bourguignon, Fanie, Thériault, William P., Longpré, Jessie, Thibodeau, Alexandre, Fravalo, Philippe“…L. monocytogenes isolates were not stochastically distributed on the surfaces: the isolates were detected on three out of six production lines, each associated with a specific meat cut: the half carcasses, the bostons and the picnics. MaAsLin biomarker analysis identified the taxa Veillonella (p ≤ 0.0397) as a bacterial determinant of the presence of L. monocytogenes on processing surfaces. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto